4.6 Article

Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway

Journal

CELLULAR SIGNALLING
Volume 23, Issue 5, Pages 883-892

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cellsig.2011.01.014

Keywords

Keap1; p65; Nrf2-ARE

Categories

Funding

  1. Special Funds for Major State Basic Research of China [2006CB910802, 2011CB910600, 2010CB911904]
  2. Chinese National High-tech Program [2006AA02A310]
  3. National Natural Science Foundation of China [30900755, 90813030]
  4. National Key Technologies R&D Program for New Drugs [2009ZX09301-002]

Ask authors/readers for more resources

Keap1 is an inhibitor of Nrf2 involved in Nrf2-dependent antioxidant response. However, the mechanisms on how Keap1 regulates Nrf2-ARE signaling pathway remains to be determined. Here, by using a yeast two-hybrid technology, p65 subunit of NF-kappa B transcription factor was identified as a partner of Keap1. We show that Keap1 physically associated with p65 in vivo and in vitro. Overexpression of p65 inhibited Nrf2-dependent transcription induced by diethylmaleate (DEM) or tert-butyl hydroxyquinone (tBHQ). Knock down of Keap1 by RNA interference partially blocked the repression of Nrf2-mediated activation by p65. It was demonstrated that p65 decreased Nrf2 binding to its cognate DNA sequences and enhanced Nrf2 ubiquitination. The N-terminal region of p65 is necessary for both the interaction with Keap1 and its transcriptional suppression activity. Moreover, nuclear translocation of Keap1 was augmented by p65. Taken together, our findings suggest that NF-kappa B signaling inhibits Nrf2-ARE pathway through the interaction of p65 and Keap1. (C) 2011 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available